Eutropics Pharmaceuticals

Eutropics is co-developing a companion diagnostic/therapeutic for the treatment of multiple myeloma patients.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Cambridge, MA, USA
  • Currency USD
  • Founded July 2005
  • Employees 5
  • Incorporation Type C-corp
  • Website eutropics.com

Company Summary

Eutropics is a biomarker discovery and clinical diagnostics, CLIA laboratory in Cambridge, MA. Eutropics provides a novel and validated assay platform.
Our test platform recognizes apoptotic potential of biopsied cancer cells by assessing "BCL2, oncogene dependencies" using novel "PRIMAB" antibodies. We anticipate wide application of the platform as commercial diagnostic tests and as companion diagnostic (CDx) tests.

Team

  • Michael Cardone
    Founder/CEO

  • Mike Cardone

  • Jason Walsh
    CFO (INT)

    20 years experience in biotech in Operations and Financial Executive positions

Previous Investors

  • NIH-NCI SBIR |Mass Life Sciences accelerator program|Several early investors made small investments
    Unconfirmed
    Mass Ventures
    Unconfirmed
    Investment from Century Holding
    Unconfirmed
  • MILLSTONE FOUNDATION
    Unconfirmed
    Bill Coppel
    Unconfirmed
    Clifford Haugen

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free